Page last updated: 2024-08-23

n-nitrosoiminodiacetic acid and buprenorphine, naloxone drug combination

n-nitrosoiminodiacetic acid has been researched along with buprenorphine, naloxone drug combination in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Costello, E; Novo, P; Nunes, EV; Rotrosen, J; Shulman, M; Weiss, R	1

Reviews

1 review(s) available for n-nitrosoiminodiacetic acid and buprenorphine, naloxone drug combination

Article	Year
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)". Addiction science & clinical practice, 2021, 03-06, Volume: 16, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Naltrexone; Narcotic Antagonists; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; United States	2021

Article

Year

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".

Addiction science & clinical practice, 2021, 03-06, Volume: 16, Issue:1

Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Naltrexone; Narcotic Antagonists; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2021